Table 2

Time duration and delay in different segments from onset to care among patients with STEMI (min)

All patients with STEMIThrombolytic therapy patientsNon-thrombolytic therapy patientsP value*
Symptoms onset-to-arrival time
 Time duration, median (IQR)210 (110–660)140 (70–240)360 (130–1364)<0.01
 Delay, % (no. of cases/total number)67.1 (4903/7312)54.6 (1669/3057)76.0 (3234/4255)<0.01
Arrival-to-ECG time
 Time duration, median (IQR)5 (0–17)4 (0–10)6 (0–24)<0.01
 Delay, % (no. of cases/total number)31.4 (2299/7312)23.6 (722/3057)37.1 (1577/4255)<0.01
ECG-to-thrombolytic therapy time
 Time duration, median (IQR)38 (20–65)
 Delay, % (no. of cases/total number)85.8 (2623/3057)
Arrival-to-thrombolytic therapy time
 Time duration, median (IQR)47 (27–80)
 Delay, % (no. of cases/total number)67.8 (2072/3057)
Total time
 Time duration, median (IQR)260 (145–710)†210 (135–320)395 (157–1419)‡
  • *Comparison between thrombolytic therapy patients and non-thrombolytic therapy patients.

  • †Representing symptoms onset-to-thrombolytic therapy time among those who received thrombolytic therapy but symptoms onset-to-ECG time among those who did not receive thrombolytic therapy.

  • ‡Representing onset-to-ECG time.

  • STEMI, ST-segment elevation myocardial infarction.